Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

On The Cusp Of Biosimilars: Reform Ushers In Next Generic Drug Era

Mar 29 2010

• By The Pink Sheet

Related Content

Playing Catch-Up: Mylan And Biocon To Team Up On Generic Biologics

Jun 29 2009

Pfizer Thinks Small: Partnership With Protalix On Gaucher Drug Eyes Cheaper Plant-Based Production

Dec 07 2009

Teva, Eyeing Follow-Ons For Most Biologics, Starts With Amgen's Neupogen

Dec 07 2009

Teva Adds To Biosimilars Capabilities Through Partnership With Lonza

Jan 26 2009

Merck’s Ambitious Plans For Follow-On Biologics

Dec 15 2008

FOB Guidances From FDA Could Be Issued By End Of 2010, Hospira Says

Mar 29 2010

Follow-on Biologic's Day Will Come - Post 2015, Teva Says

Jan 12 2010

Fresh Start For Insmed, Added Biosimilar Capabilities For Merck In $130M Deal

Feb 12 2009

Omnitrope’s Improved Delivery System Already Getting Formulary Traction

Jan 28 2008

Korea's Celltrion In Deal With U.S.-based Hospira For Biogeneric Sales; M&A Hinted At

Oct 12 2009

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window